This study is investigating if adding pilocarpine (a glaucoma medication) improves the success of combined cataract surgery with Kahook Dual Blade (KDB) for people with glaucoma or ocular hypertension (high eye pressure). The KDB procedure helps lower eye pressure by improving fluid drainage. Pilocarpine works by opening up the eye's drainage system. The study aims to see what percentage of patients experience lower eye pressure for up to one year after the procedure. You may be able to join if you are between 30 and 100 years old, have open-angle glaucoma or ocular hypertension, and are having this specific combined surgery at Montefiore Medical Center. You cannot have had previous eye surgeries. The current status of this study is unclear.

Study design

This is an interventional study with a planned enrollment of 142 participants. It is not specified if it is randomized or blinded.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for one year after the procedure to measure changes in intraocular pressure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.